India to Oman Pharmaceutical Export (2026) — $58.3M, 371 Suppliers | TransData Nexus

India to Oman Pharmaceutical Export (2026) — $58.3M, 371 Suppliers | TransData Nexus | TransData Nexus

Top Pharmaceutical Formulations — India to Oman

#	Formulation	Value	Share
1	Drez 10% Solution 100ml Batch No;22-xdts	$2.1M	3.6%
2	An3 Ca; Endometrial Carcinoma; Human (ho	$553.5K	0.9%
3	Orabenz Gel 15g Batch No; Xobg-007 Mfg.d	$531.0K	0.9%
4	Melamet Cream Hydroquinone USP Tretinoin USP Mometasone Furoate IP in a Cream B…	$527.9K	0.9%
5	Neuro-2a; Neuroblastoma Mouse (musmuscul	$433.0K	0.7%
6	Sw480; Colon Adenocarcinoma; Human (homo	$433.0K	0.7%
7	R1_95-2 Endometrial Carcinoma; Human (ho	$433.0K	0.7%
8	Nih: Ovcar-3; Ovarian Adenocarcinoma; Hu	$433.0K	0.7%
9	293t; Embryonic Kidney Cells; Human (hom	$433.0K	0.7%
10	Siha; Cervical Carcinoma; Human (homo Sa	$433.0K	0.7%
11	Mcf7; Breast Adenocarcinoma; Human (homo	$433.0K	0.7%
12	Hep G2 Hepatocellular; Carcinoma; Human	$433.0K	0.7%
13	Panc-1; Pancreatic Carcinoma; Human (hom	$433.0K	0.7%
14	Hela; Cervical Adenocarcinoma-ccl-2 (1ml	$433.0K	0.7%
15	C-33 A; Cervical Carcinoma; Human (homo	$433.0K	0.7%

India exports 20+ pharmaceutical formulations to Oman with a combined trade value of $58.3M.. These are finished dosage forms — tablets, capsules, injectables, and combination drugs — shipped from Indian manufacturing facilities with FDA, WHO-GMP, and EU GMP certifications. Data from 11,419 verified Indian Customs (DGFT) shipment records.

Top Indian Exporters to Oman

1Next-gen Bio

$6.2M

2Cipla Limited

$3.8M

3Sun Pharmaceutical Industries Limited

$3.8M

4Swasam Bookart

$3.1M

5Glenmark Pharmaceuticals Limited

Port Analysis — India to Oman Pharmaceutical Shipments

Indian Export Ports

CHENNAI AIR0.9%

NHAVA SHEVA SEA (INNSA1)8.4%

SAHAR AIR16.2%

SAHAR AIR CARGO ACC (INBOM4)16.8%

JNPT/ NHAVA SHEVA SEA3.5%

Oman Import Ports

MUSCAT52.7%

Sohar11.0%

SALALAH10.4%

Salalah8.2%

SOHAR5.4%

Trade Statistics

Total Value$58.3M

Shipments11,419

Indian Exporters371

Oman Buyers447

Avg Shipment$5K

Products7,886

Other Destinations

United States$8.8B United Kingdom$1.2B Canada$1.1B France

Last updated: March 28, 2026

India–Oman Pharmaceutical Trade Corridor Analysis

Historical evolution, India's market position, and recent developments

1Trade Corridor Evolution

The India-Oman pharmaceutical trade corridor has experienced significant growth over the past decade. In 2013-14, India's pharmaceutical exports to Oman were valued at approximately $30 million. By 2024, this figure had increased to $52.44 million, reflecting a substantial rise in bilateral trade. This growth is attributed to India's competitive pricing, adherence to international quality standards, and Oman's increasing demand for affordable healthcare solutions.

A pivotal development occurred in December 2025 with the signing of the Comprehensive Economic Partnership Agreement (CEPA) between India and Oman. This agreement granted Indian pharmaceutical products duty-free access to the Omani market, including finished medicines and vaccines. Additionally, the CEPA introduced fast-track marketing authorizations for products approved by stringent regulatory authorities such as the USFDA, EMA, UK's MHRA, and Australia's TGA. These measures have streamlined the registration process, reducing approval timelines and compliance costs for Indian exporters.

2India's Market Position

India holds a dominant position in Oman's pharmaceutical imports, accounting for a significant share of the market. In 2024, India's pharmaceutical exports to Oman were valued at $52.44 million, making it one of the leading suppliers to the Omani market. This strong market presence is bolstered by India's extensive portfolio of generic medicines, competitive pricing, and compliance with international quality standards. The CEPA further enhances India's strategic importance, providing near-universal duty-free access to the Omani market and facilitating faster market entry for Indian pharmaceutical products.

Oman Regulatory Landscape for Indian Pharmaceutical Exports

Registration process, GMP requirements, import documentation

1Registration Process

Indian pharmaceutical companies seeking to register products in Oman must adhere to the guidelines set by Oman's National Drug Regulatory Authority, which follows WHO-GMP standards. The registration process involves submitting a comprehensive dossier, typically in the Common Technical Document (CTD) or electronic CTD (eCTD) format, detailing the product's quality, safety, and efficacy. Oman accepts Good Manufacturing Practice (GMP) certificates and inspection outcomes from recognized stringent regulatory authorities, including the USFDA, EMA, UK's MHRA, and Australia's TGA. This mutual recognition reduces duplication and compliance costs for Indian exporters. The CEPA further facilitates the registration process by allowing products approved by these authorities to receive marketing authorization within 90 days, subject to submission of complete assessment dossiers.

2GMP & Facility Requirements

Oman requires Indian manufacturing sites to comply with WHO-GMP standards. The inspection process involves evaluating the manufacturing facilities to ensure they meet these international quality standards. Oman accepts GMP certificates and inspection outcomes from recognized stringent regulatory authorities, including the USFDA, EMA, UK's MHRA, and Australia's TGA. This mutual recognition reduces duplication and compliance costs for Indian exporters. The CEPA further facilitates the registration process by allowing products approved by these authorities to receive marketing authorization within 90 days, subject to submission of complete assessment dossiers.

3Import Documentation

To import pharmaceutical products into Oman, Indian exporters must provide several key documents:

Certificate of Pharmaceutical Product (CPP): Confirms the product's registration and compliance with GMP standards.

Certificate of Analysis (CoA): Details the product's quality and composition.

GMP Certificate: Verifies that the manufacturing facility adheres to WHO-GMP standards.

These documents are essential for customs clearance and regulatory approval in Oman. The CEPA has streamlined the import process by providing duty-free access and expediting regulatory approvals for Indian pharmaceutical products.

TransData Nexus Research · Oman regulatory databasesMar 2026

FAQ — India to Oman Pharmaceutical Trade

What is the total value of India's pharmaceutical export to Oman?

India exported pharmaceuticals worth $58.3M to Oman across 11,419 verified shipments.

Who are the top Indian pharmaceutical exporters to Oman?

1. NEXT-GEN BIO — $6.2M. 2. CIPLA LIMITED — $3.8M. 3. SUN PHARMACEUTICAL INDUSTRIES LIMITED — $3.8M. Total: 371 suppliers.

Which companies in Oman import pharmaceuticals from India?

1. BUSINESS INTERNATIONAL GROUP LLC — $6.2M. 2. CAPITAL PHARMACY — $3.9M. 3. AL JABRY PHARMACY — $3.4M. 447 buyers total.

What pharmaceutical products does India export most to Oman?

1. Drez 10% Solution 100ml Batch No;22-xdts ($2.1M, 3.6%); 2. An3 Ca; Endometrial Carcinoma; Human (ho ($553.5K, 0.9%); 3. Orabenz Gel 15g Batch No; Xobg-007 Mfg.d ($531.0K, 0.9%); 4. Melamet Cream Hydroquinone USP Tretinoin USP Mometasone Furoate IP in a Cream B… ($527.9K, 0.9%); 5. Neuro-2a; Neuroblastoma Mouse (musmuscul ($433.0K, 0.7%)

Which ports handle pharmaceutical shipments from India to Oman?

Export: CHENNAI AIR, NHAVA SHEVA SEA (INNSA1), SAHAR AIR, SAHAR AIR CARGO ACC (INBOM4), JNPT/ NHAVA SHEVA SEA. Import: MUSCAT, Sohar, SALALAH, Salalah, SOHAR.

Why does Oman import pharmaceuticals from India?

India's cost-competitive generic drug manufacturing, WHO-GMP certified facilities, and broad product portfolio. This $58.3M corridor reflects quality compliance and pricing advantages.

What certifications do Indian pharmaceutical exporters need to supply Oman?

WHO-GMP certification, EU GMP approval (for EU markets), product dossier registration (CTD format), and ICH guideline compliance.

What is the average shipment value for India to Oman pharmaceutical trade?

$5.1K per consignment across 11,419 shipments.

How many Indian pharmaceutical companies export to Oman?

371 Indian companies. Largest: NEXT-GEN BIO with $6.2M.

How can I find verified Indian pharmaceutical suppliers for Oman?

TransData Nexus covers 371 active exporters with shipment history and trade values at transdatanexus.com.

Research Methodology & Data Transparency

Suresh Sormare

Verified Author

Pharmaceutical Export-Import Analyst & Trade Intelligence Expert

Suresh Sormare is a pharmaceutical export-import analyst with deep expertise in Indian Customs (DGFT) data, HS code classification, and global pharmaceutical supply chains. His analysis covers 10M+ shipment records across 150+ countries and is used by manufacturers, procurement agencies, and trade consultants worldwide. Suresh specializes in identifying verified suppliers and buyers from customs records, mapping bilateral pharmaceutical trade corridors, analyzing tariff structures and regulatory frameworks across 170+ destination markets, and benchmarking competitive positioning for finished pharmaceutical formulations. His methodology combines granular customs transaction data with regulatory intelligence from FDA, EMA, WHO, CDSCO, and 40+ national drug authorities to deliver actionable trade insights for the pharmaceutical formulations sector.

linkedin.com/in/sureshsormare

Primary Data Source

All trade data is sourced from Indian Customs (DGFT) official shipping bill records — the authoritative government database for India's pharmaceutical trade. Each verified record contains exporter name, consignee (buyer) name, detailed product description, quantity, declared FOB value (USD), port of loading, destination country, and shipment date.

Analysis Methodology

1.Data Source: Indian Customs (DGFT) export shipping bill records covering all pharmaceutical shipments from India.
2.Country Matching: Shipments to Oman identified using destination country codes from customs declarations.
3.Statistical Normalization: Values are statistically normalized to remove outlier transactions and ensure accurate market share representation.
4.Coverage: 11,419 verified shipments from 371 Indian exporters to 447 Oman buyers.

Government-Sourced Data

Official DGFT customs records

Transparent Methodology

Calculations fully disclosed above

371 Exporters

447 buyers tracked

Expert-Reviewed

By pharmaceutical trade specialists

India to Oman Pharmaceutical Export

Top Pharmaceutical Formulations — India to Oman

Top Indian Exporters to Oman

Port Analysis — India to Oman Pharmaceutical Shipments

Indian Export Ports

Oman Import Ports

Trade Statistics

Other Destinations

India–Oman Pharmaceutical Trade Corridor Analysis

1Trade Corridor Evolution

2India's Market Position

Top Oman Buyers from India

Full Dataset Access

3Recent Developments

Oman Regulatory Landscape for Indian Pharmaceutical Exports

1Registration Process

2GMP & Facility Requirements

3Import Documentation

Product Categories & Therapeutic Trends — India to Oman

1Dominant Categories

2Emerging Opportunities

3Demand Drivers

Trade Policy & Tariff Intelligence — India and Oman

1Tariff & Duty Structure

2Trade Agreements

3IP & Patent Landscape

Supply Chain & Logistics — India to Oman Pharma Shipments

1Shipping Routes & Transit

2Port Infrastructure

3Cold Chain & Compliance